Xgeva and Bacteraemia - a phase IV clinical study of FDA data

Summary:

Bacteraemia is reported as a side effect among people who take Xgeva (denosumab), especially for people who are male, 60+ old, also take Ibrance, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Bacteraemia when taking Xgeva. It is created by eHealthMe based on reports of 37,636 people who have side effects when taking Xgeva from the FDA, and is updated regularly.

What is Xgeva?

Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 37,717 Xgeva users. Check the latest studies of Xgeva.

What is Bacteraemia?

Bacteraemia (presence of bacteria in the blood) is found to be associated with 1,023 drugs and 1,517 conditions by eHealthMe. Check the latest studies of Bacteraemia.



On Jul, 13, 2026

37,636 people reported to have side effects when taking Xgeva.
Among them, 30 people (0.08%) have Bacteraemia.

Could Xgeva cause Bacteraemia?

Among these 30 people:

What is the gender of people who have Bacteraemia when taking Xgeva? *

  • female: 27.59 %
  • male: 72.41 %

What is the age of people who have Bacteraemia when taking Xgeva? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 17.86 %
  • 50-59: 7.14 %
  • 60+: 75.0 %

What are other drugs people take besides Xgeva? *

  1. Ibrance: 6 people, 20.00%
  2. Zoladex: 5 people, 16.67%
  3. Femara: 5 people, 16.67%
  4. Glucophage: 5 people, 16.67%
  5. Tecentriq: 5 people, 16.67%
  6. Levemir: 5 people, 16.67%
  7. Lisinopril: 5 people, 16.67%
  8. Prilosec: 4 people, 13.33%
  9. Atenolol: 4 people, 13.33%
  10. Azithromycin: 4 people, 13.33%

What are other side effects people have besides Bacteraemia? *

  1. Weakness: 7 people, 23.33%
  2. Urinary Tract Infection: 7 people, 23.33%
  3. Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 6 people, 20.00%
  4. Cellulitis (infection under the skin): 6 people, 20.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 20.00%
  6. Anaemia (lack of blood): 6 people, 20.00%
  7. Blood Creatinine Decreased: 5 people, 16.67%
  8. Immunodeficiency Disorders: 5 people, 16.67%
  9. Infection: 5 people, 16.67%
  10. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 16.67%

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 7 people, 23.33%
  2. Small Cell Lung Cancer Metastatic (lung cancer spreads to other body parts): 6 people, 20.00%
  3. Bone Giant Cell Tumor: 4 people, 13.33%
  4. Prostate Cancer Metastatic: 3 people, 10.00%
  5. Oncologic Complication: 2 people, 6.67%
  6. Ventricular Extrasystoles (premature cardiac contraction): 1 person, 3.33%
  7. Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 3.33%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 3.33%
  9. High Blood Pressure: 1 person, 3.33%
  10. Hormone Level Abnormal: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xgeva and have Bacteraemia?

- Check whether Bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xgeva:

Bacteraemia treatments and more:

How severe was Bacteraemia and when was it recovered:

Expand to all the drugs that have ingredients of denosumab:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xgeva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bacteraemia:

Browse all the conditions that are associated with Bacteraemia:


How the study uses the data?

The study uses data from the FDA. It is based on denosumab (the active ingredients of Xgeva) and Xgeva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: